Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut J Ehrlich

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Proteomics|August 19, 2009
A close look at human IgG sialylation and subclass distribution after lectin fractionationJohannes Stadlmann, Alfred Weber, Martin Pabst, et al.
Vaccine|January 18, 2003
Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillanceBorislava G Pavlova, Alexandra Loew-Baselli, Sandor Fritsch, et al.
Scientific Reports|July 9, 2017
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated MacrophagesKarim Chebli, Laura Papon, Conception Paul, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
Lancet (London, England)|February 19, 2011
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trialP Noel Barrett, Gregory Berezuk, Sandor Fritsch, et al.
Human Vaccines|May 12, 2009
Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 yearsAlexandra Loew-Baselli, Eva-Maria Poellabauer, Borislava G Pavlova, et al.
Vaccine|May 16, 2013
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infantsEva-Maria Poellabauer, Borislava G Pavlova, Sandor Fritsch, et al.
Transfusion|November 22, 2007
Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidasesH Peter Matthiessen, Johan Willemse, Alfred Weber, et al.
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Proteomics|August 19, 2009
A close look at human IgG sialylation and subclass distribution after lectin fractionationJohannes Stadlmann, Alfred Weber, Martin Pabst, et al.
Vaccine|January 18, 2003
Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillanceBorislava G Pavlova, Alexandra Loew-Baselli, Sandor Fritsch, et al.
Scientific Reports|July 9, 2017
The Anti-Hiv Candidate Abx464 Dampens Intestinal Inflammation by Triggering Il-22 Production in Activated MacrophagesKarim Chebli, Laura Papon, Conception Paul, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjectsDidier Scherrer, Regine Rouzier, P Noel Barrett, et al.
Lancet (London, England)|February 19, 2011
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trialP Noel Barrett, Gregory Berezuk, Sandor Fritsch, et al.
Human Vaccines|May 12, 2009
Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 yearsAlexandra Loew-Baselli, Eva-Maria Poellabauer, Borislava G Pavlova, et al.
Vaccine|May 16, 2013
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infantsEva-Maria Poellabauer, Borislava G Pavlova, Sandor Fritsch, et al.
Transfusion|November 22, 2007
Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidasesH Peter Matthiessen, Johan Willemse, Alfred Weber, et al.
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Pageof 5